Half the UK population will get cancer during their lifetime - and rates are rising. Each year, around 385,000 people in the UK are diagnosed and around 167,00 lives are lost to the disease. But scientists are developing new therapies, including personalised vaccines and targeted drugs, that attack cancer cells directly and more effectively. It's hoped this pioneering work could lead to better survival rates.
David Aaronovitch and guests discuss promising developments in cancer care - to find out how significant they might be.

Guests:
Professor Charles Swanton, chief clinician at Cancer Research UK and deputy clinical director at the Francis Crick Institute;
Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery at the Institute of Cancer Research;
Christian Ottensmeier, Professor of Immuno-Oncology at the University of Liverpool;
Professor Alan Melcher, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust

Presenter: David Aaronovitch
Producers: Rosamund Jones and Sally Abrahams
Sound engineers: Rod Farquhar and Neil Churchill
Editor: Richard Vadon